Search research articles
Contact Us
Filters
Showing results (61-70 of 78) with videos related to
Page
of 8
Sort By:
Proceedings of the National Academy of Sciences of the United States of America
|
November 22, 2012
Inhibition of glutamate carboxypeptidase II (GCPII) activity as a treatment for cognitive impairment in multiple sclerosis
Kristen A Rahn, Crystal C Watkins, Jesse Alt, et al.
Molecular Cancer Therapeutics
|
October 10, 2019
The Novel Glutamine Antagonist Prodrug JHU395 Has Antitumor Activity in Malignant Peripheral Nerve Sheath Tumor
Kathryn M Lemberg, Liang Zhao, Ying Wu, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology
|
March 14, 2019
Correction: JHU-083 selectively blocks glutaminase activity in brain CD11b<sup>+</sup> cells and prevents depression-associated behaviors induced by chronic social defeat stress
Xiaolei Zhu, Michael T Nedelcovych, Ajit G Thomas, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology
|
August 22, 2018
JHU-083 selectively blocks glutaminase activity in brain CD11b<sup>+</sup> cells and prevents depression-associated behaviors induced by chronic social defeat stress
Xiaolei Zhu, Michael T Nedelcovych, Ajit G Thomas, et al.
Molecular Cancer Therapeutics
|
August 24, 2023
Pro-905, a Novel Purine Antimetabolite, Combines with Glutamine Amidotransferase Inhibition to Suppress Growth of Malignant Peripheral Nerve Sheath Tumor
Kathryn M Lemberg, Eunus S Ali, Marcela Krecmerova, et al.
Cell Death & Disease
|
April 28, 2022
Dual mTORC1/2 inhibition compromises cell defenses against exogenous stress potentiating Obatoclax-induced cytotoxicity in atypical teratoid/rhabdoid tumors
Ashlyn Parkhurst, Sabrina Z Wang, Tyler R Findlay, et al.
Molecular Pharmaceutics
|
August 2, 2017
Enhanced Brain Delivery of 2-(Phosphonomethyl)pentanedioic Acid Following Intranasal Administration of Its γ-Substituted Ester Prodrugs
Michael Nedelcovych, Ranjeet P Dash, Lukáš Tenora, et al.
Frontiers in Pharmacology
|
October 31, 2025
Mass spectrometry-guided discovery of novel GCPII inhibitor scaffolds
Robyn Wiseman, Ajit G Thomas, John Janiszewski, et al.
Journal of Medicinal Chemistry
|
September 10, 2019
Discovery of Benzamidine- and 1-Aminoisoquinoline-Based Human MAS-Related G-Protein-Coupled Receptor X1 (MRGPRX1) Agonists
Eva Prchalová, Niyada Hin, Ajit G Thomas, et al.
Journal of Neuroimmune Pharmacology : the Official Journal of the Society on Neuroimmune Pharmacology
|
June 19, 2019
Glutamine Antagonist JHU083 Normalizes Aberrant Glutamate Production and Cognitive Deficits in the EcoHIV Murine Model of HIV-Associated Neurocognitive Disorders
Michael T Nedelcovych, Boe-Hyun Kim, Xiaolei Zhu, et al.
Page
of 8
Search research articles
Search
Showing results (61-70 of 78) with videos related to
Sort By:
Page
of 8
Proceedings of the National Academy of Sciences of the United States of America
|
November 22, 2012
Inhibition of glutamate carboxypeptidase II (GCPII) activity as a treatment for cognitive impairment in multiple sclerosis
Kristen A Rahn, Crystal C Watkins, Jesse Alt, et al.
Molecular Cancer Therapeutics
|
October 10, 2019
The Novel Glutamine Antagonist Prodrug JHU395 Has Antitumor Activity in Malignant Peripheral Nerve Sheath Tumor
Kathryn M Lemberg, Liang Zhao, Ying Wu, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology
|
March 14, 2019
Correction: JHU-083 selectively blocks glutaminase activity in brain CD11b<sup>+</sup> cells and prevents depression-associated behaviors induced by chronic social defeat stress
Xiaolei Zhu, Michael T Nedelcovych, Ajit G Thomas, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology
|
August 22, 2018
JHU-083 selectively blocks glutaminase activity in brain CD11b<sup>+</sup> cells and prevents depression-associated behaviors induced by chronic social defeat stress
Xiaolei Zhu, Michael T Nedelcovych, Ajit G Thomas, et al.
Molecular Cancer Therapeutics
|
August 24, 2023
Pro-905, a Novel Purine Antimetabolite, Combines with Glutamine Amidotransferase Inhibition to Suppress Growth of Malignant Peripheral Nerve Sheath Tumor
Kathryn M Lemberg, Eunus S Ali, Marcela Krecmerova, et al.
Cell Death & Disease
|
April 28, 2022
Dual mTORC1/2 inhibition compromises cell defenses against exogenous stress potentiating Obatoclax-induced cytotoxicity in atypical teratoid/rhabdoid tumors
Ashlyn Parkhurst, Sabrina Z Wang, Tyler R Findlay, et al.
Molecular Pharmaceutics
|
August 2, 2017
Enhanced Brain Delivery of 2-(Phosphonomethyl)pentanedioic Acid Following Intranasal Administration of Its γ-Substituted Ester Prodrugs
Michael Nedelcovych, Ranjeet P Dash, Lukáš Tenora, et al.
Frontiers in Pharmacology
|
October 31, 2025
Mass spectrometry-guided discovery of novel GCPII inhibitor scaffolds
Robyn Wiseman, Ajit G Thomas, John Janiszewski, et al.
Journal of Medicinal Chemistry
|
September 10, 2019
Discovery of Benzamidine- and 1-Aminoisoquinoline-Based Human MAS-Related G-Protein-Coupled Receptor X1 (MRGPRX1) Agonists
Eva Prchalová, Niyada Hin, Ajit G Thomas, et al.
Journal of Neuroimmune Pharmacology : the Official Journal of the Society on Neuroimmune Pharmacology
|
June 19, 2019
Glutamine Antagonist JHU083 Normalizes Aberrant Glutamate Production and Cognitive Deficits in the EcoHIV Murine Model of HIV-Associated Neurocognitive Disorders
Michael T Nedelcovych, Boe-Hyun Kim, Xiaolei Zhu, et al.
Page
of 8